HeadlinesBriefing favicon HeadlinesBriefing

Sector Investment 3 Days

×
8 articles summarized · Last updated: LATEST

Last updated: May 23, 2026, 8:33 AM ET

Real Estate Fundraising & Investment Trends

Kayne Anderson secured a record $5.2 billion fund for niche real estate opportunities, with the over-subscribed seventh flagship opportunistic fund targeting medical offices, senior housing, and student housing. Meanwhile, CPP reported flat real estate returns at 3.7% for fiscal 2026 while reallocating from retail and office properties toward global data center investments. In a sign of shifting market dynamics, Sumitomo Mitsui DS Asset Management adopted a more conservative approach to fund selection, prioritizing diversification across asset classes. Australian investors are also showing renewed interest, with CSC identifying "relative value" in real estate as the market appears to have turned according to Glenn Riley, prompting increased deployment in the sector.

Data Center & Secondary Market Growth

As institutional investors continue to pivot toward digital infrastructure assets, Blackstone launched a public REIT targeting hyperscale data center properties, potentially providing an exit channel for managers in the red-hot sector. This move comes amid CPP's significant commitments to global data centers, reflecting the broader industry shift away from traditional office and retail spaces. The real estate secondary market has also expanded substantially, with global transaction volume increasing and larger-scale liquidity structures becoming a mainstream feature as both GPs and LPs seek flexibility in private markets.

Healthcare & Life Sciences Investment

The healthcare secondary market has grown to approximately $220 billion as GPs and LPs pursue liquidity options in a private markets cycle characterized by "worse distribution profiles" for the past three and a half years. In direct investment activity, Eir Partners acquired a controlling interest in Quartz Bio, a Maryland-based life science technology company founded in 2012, expanding its presence in the healthcare and life sciences sector.